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AIG, autoimmune gastritis; 
AIH, autoimmune hepatitis; 
ANA, anti-nuclear antibody; 
IFN, interferon; 
H. pylori, Helicobacter pylori; 
NTx, neonatal thymectomy;  
NTx mice, mice thymectomized three days after birth; 
PD-1, programmed cell death 1; 
Th1, T helper 1; 
Treg, CD4+CD25+ regulatory T 
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Abstract 
Interferon (IFN)-γ acts as a critical proinflammatory mediator in autoimmune 
processes, whereas it exerts regulatory functions to limit tissue damage associated with 
inflammation. However, a detailed understanding of the complex roles of IFN-γ  in the 
development of organ-specific autoimmunity is still lacking. Recently, we found that 
programmed cell death 1 (PD-1)–deficient mice thymectomized three days after birth 
(NTx–PD-1-/- mice) concurrently developed autoimmune hepatitis (AIH) and 
autoimmune gastritis (AIG). In this study, we investigated the roles of IFN-γ in the 
development of AIH and AIG in this mouse model. In NTx–PD-1-/- mice, serum levels 
of IFN-γ were markedly elevated. Neutralization of IFN-γ prevented the development 
of AIG. However, the same treatment exacerbated hepatic T-cell infiltration in AIH. 
Because of the loss of anti-proliferative effects by IFN-γ, neutralization of IFN-γ 
increased T cell proliferation in the spleen and liver, resulting in exacerbated T-cell 
infiltration in the liver. On the other hand, in the development of AIG, CD4+ T-cell 
migration into the gastric mucosa is essential for induction. CCL20 expression was 
upregulated in the gastric mucosa, and anti-CCL20 suppressed CD4+ T-cell infiltration 
into the gastric mucosa. Importantly, anti-IFN-γ suppressed CCL20 expression and 
infiltration of CD4+ T cells in the gastric mucosa, whereas in vivo injection of 
recombinant IFN-γ upregulated CCL20 expression in the stomach, suggesting that 
IFN-γ is critically involved in CD4+ T-cell accumulation in AIG by upregulating local 
CCL20 expression. In conclusion, IFN-γ is involved differently in the development of 
AIH and of AIG. IFN-γ negatively regulates T-cell proliferation in fatal AIH, whereas 
it initiates development of AIG. These findings imply that increased production of 
IFN-γ induced by an organ-specific autoimmunity may trigger the concurrent 
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development of another organ-specific autoimmune disease.
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Introduction 
Interferon (IFN)-γ exerts pleiotropic effects on the immune system [1-3]. IFN-γ 
acts as a critical proinflammatory mediator in immunity and inflammation. IFN-γ 
induces macrophage activation and T helper 1 (Th1) cell response and is critically 
involved in inflammation as well as in host defense against intracellular pathogens, 
tumor surveillance, and Th1-dominated autoimmune diseases [1-3]. In contrast, IFN-γ   
exerts regulatory functions to limit tissue damage associated with inflammation [1-3]. In 
addition, IFN-γ is essential to regulate the optimal population expansion of activated 
CD4+ T cells and to maintain CD4+ T cell homeostasis during immune responses. IFN-γ 
induces apoptosis and/or suppression of proliferation in activated CD4+ T cells [4-7]. 
Moreover, it has been reported to be critically required for the conversion of CD4+CD25- 
T cells to regulatory T cells during experimental autoimmune encephalomyelitis [8]. 
Therefore, IFN-γ can either augment or suppress autoimmunity and associated tissue 
damage. However, we still lack a detailed understanding of the complex roles of IFN-γ  
in individual, organ-specific autoimmune diseases. 
In the areas of gastroenterology and hepatology, autoimmune gastritis (AIG) and 
autoimmune hepatitis (AIH) are typical organ-specific autoimmune diseases. The 
histological findings of AIG are characterized by a chronic mononuclear cell 
infiltration affecting only or predominantly the corpus mucosa and causing loss of 
parietal and chief cells from the gastric gland [9]. Its serologic hallmark is the 
production of antibody against H+K+-ATPase in the parietal cells of the stomach [10, 
11]. Mouse models of AIG share many pathological and clinical features with human 
AIG and help clarify the mechanisms involved in its development [12-14]. Mouse 
models of AIG are characterized by a marked infiltration of CD4+ T cells, which 
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produce large amounts of IFN-γ. In mice, depleted CD4+ but not CD8+ T cells or 
administrated blocking Abs to IFN-γ severely impair the development of AIG [15, 16]. 
However, the precise roles of IFN-γ in the development of CD4+ T cell-dependent AIG 
are still unclear. 
 On the other hand, human autoimmune hepatitis (AIH) appears to be a T-cell 
mediated autoimmune disease and is characterized by a mononuclear-cell infiltration 
invading the parenchyma with the production of a variety of characteristic circulating 
autoantibodies [17, 18]. Recently, we developed the first mouse model of spontaneous 
fatal AIH [19]. As adults, both programmed cell death 1-deficient mice (PD-1-/- mice) 
and BALB/c mice thymectomized three days after birth (NTx mice), a process severely 
reducing the number of naturally arising Foxp3+ regulatory T cells (Tregs) in periphery, 
developed AIG but not AIH. However, PD-1-/- BALB/c mice with neonatal 
thymectomy (NTx–PD-1-/- mice) developed AIG with fatal AIH characterized by CD4+ 
and CD8+ T-cell infiltration, with massive lobular necrosis in the liver and 
autoantibody production against nuclear antigens [19]. In NTx–PD-1-/- mice, both 
CD4+ and CD8+ T cells are indispensable for the development of fatal AIH. However, 
the infiltration of CD8+ T cells in the liver is regulated by CD4+ T cells, and CD8+ T 
cells are mainly involved in progression to fatal hepatic damage [19, 20]. In contrast, 
CD4+ T cells are responsible for induction of fatal AIH, and initial activation of CD4+ 
T cells occurs in the spleen [20]. In addition, AIG and AIH-bearing NTx–PD-1-/- mice 
at three weeks old showed markedly increased levels of IFN-γ in the serum [19]. 
However, it is not clear whether, in this mouse model, IFN-γ is essential in the 
development of AIG and/or fatal AIH. 
 In this study, we examined the roles of IFN-γ in the development of a mouse 
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model of spontaneous AIG and AIH. We found that in NTx–PD-1-/- mice, serum levels 
of IFN-γ were markedly elevated. However, neutralization of IFN-γ prevented the 
development of AIG, whereas it intensified hepatic T-cell infiltration in AIH. Because 
of the loss of anti-proliferative effects by IFN-γ, neutralization of IFN-γ increased T-cell 
proliferation in the spleen and liver, resulting in exacerbated T-cell infiltration in the 
liver. On the other hand, anti-IFN-γ suppressed upregulated CCL20-expression in the 
gastric mucosa and infiltration of CD4+ T cells in the stomach resulting in the 
impairment of the development of AIG. Taken together, our results showed that 
although AIG and AIH were simultaneously and sequentially progressed in 
NTx–PD-1-/- mice, IFN-γ is involved differently in the development of AIG and AIH. 
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Materials and Methods 
Mice 
BALB/c mice were purchased from Japan SLC (Shizuoka, Japan), and PD-1 deficient 
mice on a BALB/c background were generated as described previously [21]. These 
mice were bred and housed under specific pathogen-free conditions. Thymectomy of 
the mice three days after birth was performed as described previously [22]. All mouse 
protocols were approved by the Institute of Laboratory Animals, Graduate School of 
Medicine, Kyoto University. 
 
Real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) 
Real-time quantitative RT-PCR was performed as described previously [23]. Liver and 
gastric tissues were frozen in RNAlater (Qiagen, Hilden, Germany). RNA was extracted 
using an RNeasy mini kit (Qiagen) according to the manufacturer’s instructions. 
Single-strand complementary DNA was synthesized with SuperScriptTM II reverse 
transcriptase (Invitrogen, Carlsbad, CA). Real-time quantitative reverse-transcription 
polymerase chain reaction was performed using SYBR Green ?  Master (Roche 
Applied Science, Basel, Switzerland). Real-time quantitative reactions were performed 
with Light Cycler 480 Instrument (Roche Applied Science) according to the 
manufacturer’s instructions. Values are expressed as arbitrary units relative to 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The following primers were 
used: GAPDH: 5’-CAACTTTGTCAAGCTCATTTCC-3’ and 
5’-GGTCCAGGGTTTCTTACTCC-3’; Foxp3: 5’-TCAGGAGCCCACCAGTACA-3’ 
and 5’-TCTGAAGGCAGAGTCAGGAGA-3’; IL-10: 
5’-TTTGAATTCCCTGGGTGAGAA-3’ and 5’-GGAGAAATCGATGACAGCGC-3’; 
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T-bet: 5’-TCAACCAGCACCAGACAGAG-3’ and 
5’-AAACATCCTGTAATGGCTTGTG-3’; IFN-γ: 
5’-GGATGCATTCATGAGTATTGC-3’ and 5’-CCTTTTCCGCTTCCTGAGG-3’; 
GATA-3: 5’-TTATCAAGCCCAAGCGAAG-3’ and 
5’-TGGTGGTGGTCTGACAGTTC-3’; IL-4: 5’-TCATCGGCATTTTGAACGAG-3’ 
and 5’-CGTTTGGCACATCCATCTCC-3’; IL-13: 
5’-TGGGTGACTGCAGTCCTGGCT-3’ and 5’-GTTGCTTTGTGTAGCTGAGCA-3’; 






5’-CTGCAGATGGAGCATGTTGT-3’ and 5’-GCCATTTCTGCTTCACTGG-3’; 
IL-21: 5’-GACATTCATCATCGACCTCGT-3’ and 
5’-TCACAGGAAGGGCATTTAGC-3’ 
CCL20: 5’-ATGGCCTGCGGTGGCAAGCGTCTG-3’ and 
5’-TAGGCTGAGGAGGTTCACAGCCCT-3’; 
 
Enzyme-Linked Immunosorbent Assay (ELISA) 
Serum cytokine concentrations were measured with a mouse IFN-γ ELISA set 
(eBioscience, San Diego, CA) according to the manufacturer’s protocols. 
In vivo neutralization and injection of cytokines 
Iwamoto et. al. 
9 
NTx−PD-1-/- mice at one day after thymectomy were intraperitoneally injected every 
week with 100 µg of monoclonal antibodies (mAbs). Anti-CD4 and anti-CD8a for 
depletion of CD4+ T cells and CD8+ T cells, respectively, and neutralizing Abs to 
mouse IFN-γ were from eBioscience. Neutralizing Abs to mouse CCL20 were from 
R&D Systems (Minneapolis, MN). All isotypes were from eBioscience or R&D 
Systems. After injections, mice at day 21 or 28 after birth were sacrificed, and the liver, 
stomach, spleen and serum were harvested. PD-1-/- mice at four weeks age were 
injected intraperitoneally with 10 µg/kg of recombinant mouse IFN-γ (eBioscience). 
Before and after 2, 4, 6, or 8 hours post-injection, mice were sacrificed, and the liver, 
and stomach were harvested. 
 
Histologic and immunohistologic analysis 
Organs were fixed in neutral buffered formalin and embedded in paraffin wax. 
Sections were stained with hematoxylin and eosin for histopathology. Fluorescence 
immunohistology was performed on frozen sections as described previously [19], using 
FITC-conjugated anti-CD4, anti-CD8, or anti-CD11c (eBioscience), The degree of 
gastritis was determined according to the semiquantitative scoring system as described 
previously [24]. Chronic inflammation, characterized by the infiltration of 
mononuclear cells, was graded from 0 to 3, where 0 = no increase in the number of 
inflammatory cells, 1 = slight infiltration of the lamina propria by lymphocytes and 
plasma cells, 2 = moderately dense infiltration of the lamina propria by lymphocytes 
and plasma cells, and 3 = very dense lymphoplasma-cell infiltration in the lamina 
propria. Atrophic changes were graded from 0 to 3 according to the loss of specialized 
cells, chief and parietal cells, (0 = no loss, 1 = mild loss, 2 = moderate loss, and 3 = 
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severe loss of specialized cells). Hyperplastic changes were graded from 0 to 3 
according to hypertrophy of total gland cells, (0 = no hypertrophy, 1 = mild 
hypertrophy, 2 = moderate hypertrophy, and 3 = severe hypertrophy of total gland 
cells). 
 
Flow cytometry analysis 
Single-cell suspensions from livers and spleens were prepared as described previously 
[25, 26]. Cells were stained with PE-conjugated anti-CD3e (eBioscience) and either 
APC-conjugated anti-CD8a (eBioscience), or APC-Cy7-conjugated anti-CD4 (BD 
Biosciences, San Jose, CA). Stained cells were fixed and permeabilized using Foxp3 
staining buffer (eBioscience), and stained with FITC-conjugated anti-Ki-67 antigen. 
For 7-AAD staining, cells were stained with FITC-conjugated anti-CD3e (eBioscience) 
and 7-AAD (BD Biosciences) and either PE-Texas Red-conjugated anti-CD4 (Abcam, 
Cambridge, UK), or PE-Texas Red-conjugated anti-CD8 (Abcam). Stained cells were 
analyzed with FACSCanto
TM
 II (BD Biosciences). Data were analysed using Cell 
Quest Pro
TM (BD Biosciences). 
 
 Statistical analysis 
The data are presented as the mean values ± standard deviations. Statistical analysis 
was performed by the Student t test for pairwise comparisons and analysis of variance 
with the Tukey-Kramer test for multiple comparisons. P-values below .05 were 
considered significant. 
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Results 
Serum levels of IFN-γ are elevated in NTx–PD-1-/- mice 
 Previously we showed that, in NTx–PD-1-/- mice, hepatitis and gastritis were 
simultaneously initiated and then progressed rapidly [19]. Four days after thymectomy, 
1-week-old NTx–PD-1-/- mice had mononuclear cell infiltration neither of the stomach 
nor the liver. In contrast, two-week-old NTx–PD-1-/- mice showed moderate 
mononuclear cell infiltrations, predominantly in the portal area of the liver and in the 
lamia propria of the gastric gland. These mononuclear cell infiltrations rapidly 
progressed and were followed by massive destruction of the parenchyma of the liver 
and parietal cells in the gastric gland in three-week-old NTx–PD-1-/- mice [19]. In this 
study, first, to evaluate the roles of IFN-γ in the development of AIH and AIG, we 
examined serum levels of IFN-γ at one to three weeks of age. Previously we showed 
that severe AIG and AIH-bearing NTx–PD-1-/- mice at three weeks old showed 
increased levels of IFN-γ in the serum [19]. In this study, we found that the serum 
levels of IFN-γ were also elevated from one to two weeks of age before the 
development of autoimmunity and that the elevated serum level of IFN-γ gradually 
decreased during the progression of autoimmunity (Figure 1). These data suggest that 
in NTx–PD-1-/- mice, increased production of IFN-γ may be involved in the 
development of AIG and/or AIH. 
 
Neutralization of IFN-γ prevents the development of AIG but exacerbates inflammation 
of the liver in AIH 
Next, we evaluated whether IFN-γ is essential in the development of AIG and 
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AIH. NTx–PD-1-/- mice were injected intraperitoneally with 100 µg of neutralizing 
mAb to mouse IFN-γ or the isotype control at one day after thymectomy and then once 
a week. After four injections, mice at four weeks of age were sacrificed and the 
stomach and liver were harvested (Figure 2(A)). Although four-week-old NTx–PD-1-/- 
mice injected with the isotype control developed severe AIG with a mononuclear cell 
infiltration and a loss of parietal and chief cells in the gastric mucosa (Figure 2(B) left 
panel), four injections of anti-IFN-γ suppressed both events (Figure 2(B) right panel). 
These findings were further confirmed by a gastritis scoring system that evaluates 1) 
chronic inflammation, characterized by the infiltration of mononuclear cells; 2) 
atrophic changes based on the loss of parietal and chief cells; and 3) hyperplastic 
changes of foveolar mucus neck cells (Figure 2(C)). These data indicated that IFN-γ 
plays a critical role in the development of AIG in NTx–PD-1-/- mice.  
In contrast to AIG, neutralization of IFN-γ did not suppress, but rather 
exacerbated inflammation of the liver in AIH. Four-week-old NTx–PD-1-/- mice with 
injection of the isotype control developed severe mononuclear cell infiltration in the 
liver and a massive degeneration of hepatocytes (Figure 2(D) left panel), whereas 
injection of anti-IFN-γ showed more severe mononuclear cell infiltration in the liver 
with a massive degeneration of hepatocytes (Figure 2(D) right panel). In addition, 
injection of anti-IFN-γ revealed significantly increased serum concentrations of AST at 
four weeks of age (Figure 2(E)). 
 Because we found the most elevated serum level of IFN-γ  at one week of age 
(Figrue 1), we could not exclude the possibility that anti-IFN-γ might not neutralize 
very early production of IFN-γ  just after the NTx, resulting in the inconsistent effects 
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of anti-IFN-γ in the development of AIG and AIH. We again performed neutralizing 
experiments, adding an intraperitoneal injection of 100 µg of anti-IFN-γ or the isotype 
control at one day before thymectomy. These mice were further injected one day after 
thymectomy and then once a week with anti-IFN-γ. After five injections, mice at four 
weeks of age were sacrificed and the stomach and liver were harvested (Figrue 3(A)). 
Five injections of anti-IFN-γ also suppressed the mononuclear cell infiltration and loss 
of parietal and chief cells in the gastric mucosa (Figure 3(B)). These findings were 
further confirmed by a gastritis scoring system (Figure 3(C)). In contrast, five 
injections of anti-IFN-γ again induced more severe mononuclear cell infiltration in the 
liver with higher concentrations of AST, ALT, and total bilirubin in the serum of the 
mice at four weeks of age (Figure 3(D) and (E)). These data suggest that neutralization 
of IFN-γ suppresses the development of AIG but worsens inflammation of the liver in 
AIH, implying that IFN-γ is essential in the development of AIG, whereas it 
reciprocally acts as negative regulator for the development of AIH in NTx–PD-1-/- 
mice. 
 
Neutralization of IFN-γ exacerbates T cell infiltration in the liver 
 In the previous study, we showed that in the liver of AIH-developed 
NTx–PD-1-/- mice, infiltrating cells are mainly CD3+ T cells [19]. Infiltrating CD4+ T 
cells are predominantly localized in the portal area, whereas mainly increased CD8+ T 
cells are widely diffused in the parenchyma of the liver [19]. In this study, NTx–PD-1-/- 
mice were intraperitoneally injected, neutralizing anti-IFN-γ as described in Figure 2. 
Infiltrating cells in the liver were examined by immunohistology. We found that 
infiltrating CD4+ and CD8+ T cells were more widely and massively diffused in the 
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parenchyma under neutralization of IFN-γ in NTx–PD-1-/- mice (Figure 4(A)). 
 
Neutralization of IFN-γ does not induce aberrant differentiation into other T cell 
subsets 
 IFN-γ exerts many effects on T cell differentiation in the immune responses in 
vivo [1-3]. To investigate whether neutralization of IFN-γ induces aberrant 
differentiation of expanded T cells in the liver, we performed a global quantitative 
mRNA screening of master regulators for T-cell subsets and related cytokines—Foxp3, 
T-bet, GATA-3, RORγt, Bcl-6, IFN-γ, IL-4, IL-10, IL-13, IL-17A, IL-21 and IL-22 in 
the hepatic tissues of NTx–PD-1-/- mice at four weeks of age. Previously we showed 
that in hepatic CD4+ T cells in the progression phase of AIH at three weeks, T-bet and 
Bcl-6 expressions were upregulated [20]. In this study, we found neutralization of 
IFN-γ suppressed expression of T-bet, Bcl-6, and GATA-3 in the inflamed liver tissues 
(Figure 4(B)). However, we could not detect increased expression of any other 
molecules in the inflamed liver tissues under the neutralization of IFN-γ  (Figure 4(B)). 
These data suggest that neutralization of IFN-γ did not induce any aberrant 
differentiation of T cells in the inflamed liver. 
 
Neutralization of IFN-γ exacerbates T cell proliferation, increasing the number of T 
cells in the spleen and liver 
 During an immune response, IFN-γ optimizes the population expansion of 
activated CD4+ T cells and maintains CD4+ T cell homeostasis [1-7]. IFN-γ suppresses 
proliferation of activated CD4+ T cells, whereas IFN-γ induces apoptosis of activated 
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CD4+ T cells [4-7]. Previously, we showed that CD4+ and CD8+ T cells in the spleen 
and liver of 3-week-old NTx−PD-1-/- mice showed a CD44highCD62L-Ki-67high effector 
memory T cell phenotype with highly proliferating potential [19]. In this study, we 
examined by flow cytometry whether neutralization of IFN-γ enhanced proliferation 
and/or reduced apoptosis of activated T cells in the liver and/or spleen of 3-week-old 
NTx–PD-1-/- mice. We found that neutralization of IFN-γ increased the cell numbers of 
CD4+ T cells in the liver (Figure 5(A)). Although neutralization increased the number 
of Ki-67+ proliferating cells in CD4+ T cells of the liver, it did not reduce but rather 
increased the numbers of 7-ADD+ apoptotic cells in CD4+ T cells of the liver (Figure 
5(A)). These data are further confirmed and more significant in CD4+ and CD8+ T cells 
in the spleen (Figure 5(B)). These data suggest that in the progression of the diseases, 
neutralization of IFN-γ enhanced proliferation of T cells rather than reduction of 
apoptotic T cells, resulting in the effector T-cell expansion. 
 
Inflamed gastric mucosa in AIG contains CD4+ T cells, and depletion of CD4+ T cells 
suppresses AIG 
  Next, we examined why the neutralization of IFN-γ did not allow expanded 
effector T cells to infiltrate into the gastric mucosa. To investigate the involvement of 
the CD4+ and/or CD8+ T cells in the development of AIG, NTx–PD-1-/- mice were 
injected intraperitoneally at one day after NTx and then once a week with either 
depletion antibodies to CD4 or CD8. After four injections of anti-CD4 or anti-CD8, the 
number of CD4+ or CD8+ T cells in the periphery was greatly reduced, respectively 
(data not shown). Previously, we had shown that either depletion of CD4+ T cells or 
CD8+ T cells suppressed fatal AIH [20]. In this study, we found that depletion of CD4+ 
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T cells inhibited the development of AIG, whereas depletion of CD8+ T cells did not 
suppress AIG development (Figure 6(A) and (B)). These data suggest that CD4+ T 
cells but not CD8+ T cells are indispensable for the development of AIG. 
 Because the gastric mucosa originally does not have a lymphoid apparatus, 
CD4+ T cells may start to infiltrate into the gastric mucosa after the induction of AIG. 
Next, we monitored immunohistological findings of the stomach from 1 to 3 weeks 
(Figure 6(C)). Four days after thymectomy, 1-week-old NTx–PD-1-/- mice did not have 
any inflammation in the immature gastric gland. Although CD4+ T cells did not 
infiltrate into the gastric mucosa, CD11c+ cells existed in the lamia propria of the 
gastric gland (Figure 6(C) upper panels), where two-week-old NTx–PD-1-/- mice 
showed moderate mononuclear cell infiltrations. These infiltrations were associated 
with the increased number of CD11c+ cells and CD4+ T cells within the gastric mucosa 
(Figure 6(C) middle panels). Three-week-old NTx–PD-1-/- mice revealed that 
infiltrations of CD11c+ cells and CD4+ T cells progressed in the gastric mucosa (Figure 
6(C) lower panels). These data suugest that in NTx–PD-1-/- mice, infiltrating CD4+ T 
cells in the gastric mucosa are essential for the induction of AIG. 
 
Inflamed gastric mucosa upregulates gene expression of CCL20, and 
anti-IFN-γ treatment suppresses CCL20 expression in the stomach 
 Previous studies demonstrated that Helicobacter pylori (H. pylori) infection in 
the stomach induces upregulation of CCL20 gene expression in gastric epithelial cells 
in humans and mice [23, 27]. Because local production of chemokine CCL20 is critical 
for the migration of CCR6+ immune cells in the inflamed lesions [20, 28-30], we 
hypothesized that IFN-γ  might trigger the upregulation of CCL20 gene expression in 
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the stomach. To test this hypothesis, NTx–PD-1-/- mice were intraperitoneally injected 
with neutralizing anti-IFN-γ as described in Figure 2. In comparison with normal 
gastric mucosa in 3-week-old PD-1-/- mice, inflamed gastric mucosa in same-aged 
NTx–PD-1-/- mice showed upregulation of CCL20 gene expression (Figure 7(A)). In 
addition, neutralization of IFN-γ suppressed upregulation of CCL20 gene expression in 
the stomach (Figure 7(A)), suggesting that in the development of AIG, IFN-γ may be 
involved in upregulating CCL20 gene expression in the stomach. 
 
In vivo administration of recombinant IFN-γ induces CCL-20 expression in the 
stomach 
 Next, to examine whether IFN-γ can induce upregulated expression of CCL20 
in the stomach in vivo, four-week-old PD-1-/- mice were injected intraperitoneally with 
10 µg/kg of recombinant mouse IFN-γ. Four hours later, we found upregulated mRNA 
expression of CCL20 in the stomach but not liver (Figure 7(B)). These data confirmed 
that IFN-γ can induce upregulated expression of CCL20 in the stomach in vivo. 
 
Neutralization of either IFN-γ or CCL-20 suppresses the infiltration of CD4+ cells into 
the gastric mucosa and the development of AIG 
 Finally, we confirmed that neutralization of either IFN-γ or CCL-20 suppresses 
the infiltration of CD4+ cells into the gastric mucosa by immunohistology. NTx–PD-1-/- 
mice were intraperitoneally injected with neutralizing anti-IFN-γ or anti-CCL20, as 
described in Figure 2. After four injections, mice at four weeks of age showed that both 
neutralization of IFN-γ and CCL-20 suppressed the infiltration of CD4+ cells but not 
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CD11c+ cells into the gastric mucosa (Figure 7(C-E)). Our results, taken together, 
indicate that increased production of IFN-γ induces upregulation of CCL20 expression 
in the stomach to trigger the infiltration of CD4+ T cell in the gastric mucosa, implying 
that IFN-γ is indispensable in the development of AIG. 
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Discussion 
 In the present study, we examined the roles of IFN-γ in the development of 
spontaneous AIG and AIH in a mouse model. We found that neutralization of IFN-γ 
prevented the development of AIG, for which CD4+ T-cell migration into the gastric 
mucosa is essential. CCL20 expression was upregulated in the gastric mucosa, and 
anti-CCL20 suppressed CD4+ T-cell infiltration into the gastric mucosa. Importantly, 
anti-IFN-γ suppressed CCL20 expression and infiltration of CD4+ T cells in the gastric 
mucosa, whereas in vivo injection of rIFN-γ upregulated CCL20 expression in the 
stomach, suggesting that IFN-γ is critically involved in CD4+ T-cell accumulation into 
the gastric mucosa thorough upregulation of local CCL20 expression. In contrast, in 
AIH, neutralization of IFN-γ exacerbated hepatic T-cell infiltration. Because of the loss 
of anti-proliferative effects by IFN-γ, neutralization of IFN-γ intensified T cell 
proliferation in the spleen and liver, resulting in exacerbated T-cell infiltration in the 
liver. We therefore concluded that although AIG and AIH progress simultaneously and 
sequentially in NTx–PD-1-/- mice, IFN-γ is involved differently in the development of 
AIG and AIH. 
Using a new AIG model in which gastritis rapidly develops within four weeks of 
age, we found that in the development of AIG, CD4+ T-cell migration into the gastric 
mucosa is essential for the induction and that the IFN-γ–induced CCL20 expression 
promotes migration of CD4 T cells into the gastric mucosa. A previous study using 
mouse models characterized AIG as having a marked infiltration of CD4+ T cells, 
which produce large amounts of IFN-γ [16]. Mice with depleted CD4+ T cells or 
administered blocking Abs to IFN-γ show severely impaired development of AIG [15, 
16]. In mice treated with only a single dose of anti-IFN-γ immediately after 
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thymectomy at 3 days after birth, the incidence of AIG was severely reduced [16]. 
However, the precise roles of IFN-γ in the induction phase of AIG had not been clear. 
Our study demonstrated that in the induction phase of AIG, IFN-γ critically acts on 
CCL20 upregulation in the gastric mucosa, resulting in infiltration of CD4+ T cells. 
The CCR6-CCL20 axis plays an important role in the migration of instructed CD4+ T 
cells into target tissues, and CCR6 is expressed on Th1 cells, Th17 cells, as well as 
Treg cells in mice and humans [28-31]. Thus, CCR6 expressing Th1 cells may be 
critical for the induction of AIG. 
 In this study, we demonstrated that IFN-γ induces upregulation of CCL20 
expression in the gastric mucosa. In previous studies, H. pylori infection in the stomach 
induces chronic gastritis, and H. pylori colonization triggers upregulation of CCL20 
expression in gastric epithelial cells in humans and mice [23, 27]. However, the precise 
roles of upregulated CCL20 expression in the gastric mucosa in the development of 
gastritis had not been clear. In this study, we showed that CCL20 upregulation in the 
gastric mucosa is essential for the infiltration of CD4+ T cells, but not CD11c DCs in 
the gastric mucosa. Although precisely how IFN-γ induces CCL20 expression in the 
gastric mucosa is not clear at present, our data offer insight into the roles of CCL20 in 
the development of gastritis not only by infection but also autoimmunity. 
 Using a new spontaneous AIH model in which hepatitis rapidly and fatally 
develops within four weeks of age, we demonstrated that neutralization of IFN-γ 
exacerbated T cell infiltration in the liver and did not reduce hepatic injury. In contrast, 
IFN-γ is essential for inducing concanavalin A (Con A)-induced acute hepatic injury [32, 
33]. Con A-induced acute hepatic injury is associated with activation of NKT cells and 
T cells and is considered to be an experimental model of human AIH [25,34]. Con 
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A-induced acute hepatic injury induces rapidly increased serum levels of IFN-γ, and 
Con A-induced injury of hepatocytes was significantly reduced in neutralization of 
IFN-γ mediated signals or deficient IFN-γ [32,33]. In addition, Con A-induced injury of 
hepatocytes depends on IFN-γ through modulation of signaling by the death receptor 
Fas [32]. However, neutralization of Fas ligand did not reduce injury of hepatocytes in 
fatal AIH in NTx–PD-1-/- mice (data not shown). Because the kinetics of plasma levels 
of IFN-γ in NTx–PD-1-/- mice differ from those in Con A-induced acute hepatic injury, 
IFN-γ may clearly act as negative regulator in the development of AIH in NTx–PD-1-/- 
mice. IFN-γ is undetectable in blood circulation upon injection of Con-A into wild-type 
mice. These cytokines are detectable at 2 h after the single intravenous injection; they 
reach a maximal level within 6 h and are greatly reduced at 24 h [33, 35]. In contrast, 
high levels of IFN-γ in blood circulation were sustained in AIH-bearing NTx–PD-1-/- 
mice. 
 IFN-γ is essential to a regulatory mechanism controlling optimal population 
expansion of activated CD4+ T cells during an immune response [1-7]. IFN-γ suppresses 
proliferation of activated CD4+ T cells, whereas IFN-γ induces apoptosis of activated 
CD4+ T cells [4-7]. In mouse models of Mycobacterium bovis Bacille Calmette-Guérin 
(BCG)-infection, IFN-γ deficiency induces decreased apoptosis of activated CD4+ T 
cells and a huge expansion of these CD4+ T cells, exacerbating inflammation [5]. 
However, neutralization of IFN-γ in NTx–PD-1-/- mice induced further proliferation of 
CD4+ and CD8+ T cells but did not reduce apoptosis of these T cells. Because IFN-γ is 
reported to be critically required for the conversion of CD4+CD25- T cells to Treg cells 
during experimental autoimmune encephalomyelitis [8], converted Treg cells by IFN-γ 
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may suppress proliferation of not only CD4+ T cells but also CD8+ T cells in NTx–PD-1-/- 
mice. In contrast, we performed a global quantitative mRNA screening of IFN-γ-related 
molecules in AIH, finding that inflamed liver tissues of AIH in NTx–PD-1-/- mice 
produced larger amounts of mRNA for interferon-induced transmembrane protein 1 
(IFITM1, data not shown), which negatively regulates cell growth and is key to the 
anti-proliferative action of IFN-γ in human cell lines [36]. In addition, neutralization of 
IFN-γ suppressed IFITM1 expression (data not shown). These data suggest that direct 
and/or indirect anti-proliferative actions that depend on IFN-γ may negatively regulate 
proliferation of infiltrating T cells in Th1-dependent progression of AIH. 
 In conclusion, because IFN-γ, regarded as a proinflammatory factor and as one 
of the signature cytokines of Th1-dominated autoimmunity, can counteract harmful 
inflammation in autoimmunity, then its endogenous production — even during the 
process of the simultaneous development of AIH and AIG — results in bidirectional 
immunoregulatory consequences in moderating the pathology of NTx–PD-1-/- mice.  
Although it is not clear at present whether IFN-γ  exerts bidirectional immunoregulatory 
functions as human organ-specific autoimmune diseases are developing, our data 
highlight the unique roles of IFN-γ  in autoimmunity. Production of IFN-γ induced by 
an organ-specific autoimmunity may trigger the concurrent development of another 
organ-specific autoimmune disease. 
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Figure 1. NTx–PD-1-/- mice showed increased serum levels of IFN-γ. Serum 
IFN-γ levels of PD-1-/- mice with (closed bars) or without (open bars) NTx at one to 
three weeks of age were measured by ELISA. Data are shown as the mean of at least 
three mice. Error bars represent SD. *; P < 0.05. 
 
Figure 2. Neutralization of IFN-γ suppressed the development of AIG but 
exacerbated inflammation of the liver in AIH. (A) Protocol of in vivo neutralization 
of IFN-γ. NTx–PD-1-/- mice at one day after thymectomy were injected 
intraperitoneally (ip) every week with 100 µg of neutralizing anti-mouse IFN-γ 
(n=5) or the isotype control mAb (n=10). After four injections, mice at four weeks 
of age were sacrificed, and the stomach, liver, and serum were harvested. (B) 
Histological analysis of the stomach. The sections of tissues were fixed in formalin 
and stained with hematoxylin and eosin. (C) Gastritis score of NTx–PD-1-/- mice at 
four weeks of age treated with anti-IFN-γ or the isotype control. (D) Histological 
analysis of the liver. The sections of tissues were fixed in formalin and stained with 
hematoxylin and eosin. (E) Serum levels of the liver transaminase, AST and ALT, 
and total bilirubin. Sera from NTx–PD-1-/- mice at four weeks of age treated with 
anti-IFN-γ or the isotype control were measured. Data are shown as the mean of at 
least three mice. Error bars represent SD. *; P < 0.05. All scale bars, 100 µm. 
 
Figure 3. Neutralization of IFN-γ from one day before thymectomy suppressed the 
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development of AIG but exacerbated inflammation of the liver in AIH. (A) Protocol 
of in vivo neutralization of IFN-γ. NTx–PD-1-/- mice were injected intraperitoneally 
(ip) one day before thymectomy and every week from one day after thymectomy 
with 100 µg of neutralizing anti-mouse IFN-γ (n=5) or the isotype control mAb 
(n=10). After five injections, mice at 4 weeks of age were sacrificed, and the liver, 
stomach, and serum were harvested. (B-E) Data shown as in Fig. 2. Histological 
analysis of the stomach (B). Gastritis score (C). Histological analysis of the liver (D). 
Serum levels of the liver transaminase, AST and ALT, and total bilirubin (E). Data 
are shown as mean of at least three mice. Error bars represent SD. *; P < 0.05. All 
scale bars, 100 µm. 
 
Figure 4. Neutralization of IFN-γ exacerbated T cell infiltration in the liver, but did 
not induce aberrant differentiation into other T cell subsets. NTx–PD-1-/- mice were 
injected with or without anti-IFN-γ as described in Fig. 2. After four injections, mice 
at 4 weeks of age were sacrificed, and the livers were harvested. (A) Staining of the 
livers for hematoxylin and eosin (HE), CD4 and CD8. Scale bars, 100 µm. (B) 
Real-time quantitative RT-PCR analyses for mRNA expressions of indicated 
molecules in the liver. Data are shown as the mean of at least three mice. Error bars 
represent SD. *; P < 0.05. 
  
Figure 5. Neutralization of IFN-γ exacerbated T cell proliferation, resulting in the 
increased number of T cells in the spleen and liver. NTx–PD-1-/- mice were injected 
with or without anti-IFN-γ as described in Figure 2. After three injections, mice at 3 
weeks of age were sacrificed, and the cells were isolated from the liver (A) and the 
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spleen (B) and stained with Abs against CD3, CD4, CD8 and Ki-67 or 7-ADD. 
Percentages of indicated cells were determined by flow cytometry. Numbers of total 
cells, Ki-67+ cells or 7-ADD+ cells in CD4+ or CD8+ T cells were calculated by 
(percentage of the cells in viable cells) x (number of viable cells). Data are shown as 
the mean of at least three mice. Error bars represent SD. *; P < 0.05. 
 
Figure 6. Infiltrating CD4+ T cells in the gastric mucosa are essential for the induction 
of AIG. (A and B) NTx–PD-1-/- mice at one day after thymectomy were injected 
intraperitoneally every week with 100 µg of depletion Abs for CD4+ T cells (n=5), 
CD8+ T cells (n=5) or the isotype control (n=5). After four injections, mice at four 
weeks of age were sacrificed, and the stomachs were harvested. Histological analysis of 
the stomach. The sections of tissues were fixed in formalin and stained with 
hematoxylin and eosin. All scale bars, 100 µm (A). Gastritis score. Data are shown as 
the mean and error bars represent SD. *; P < 0.05 (B). (C) Staining of the stomach for 
hematoxylin and eosin (HE), CD11c and CD4 in NTx–PD-1-/- mice at indicated age in 
weeks. Scale bars, 50µm (left panels) and 100µm (middle and right panels). 
 
Figure 7. IFN-γ–dependent induction of CCL20 expression in the gastric mucosa is 
critical for the development of AIG. (A) NTx–PD-1-/- mice were injected with or 
without anti-IFN-γ as described in Figure 2. After three injections, mice at 3 weeks of 
age were sacrificed, and the stomachs were harvested. Real-time quantitative RT-PCR 
analyses for mRNA expressions of CCL20 in the stomachs. Data are shown as the mean 
of three mice. (B) Four-week-old PD-1-/- mice were injected intraperitoneally with 10 
µg/kg of recombinant mouse IFN-γ. At the indicated time after injection, mice were 
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sacrificed. CCL20 mRNA expressions in the stomach and liver were shown. Data are 
shown as the mean of three mice. (C and D) NTx–PD-1-/- mice were injected with 
anti-IFN-γ (n=5, C) or anti-CCL20 (n=5, D) as described in Fig. 2. After four injections, 
mice at four weeks of age were sacrificed, and the stomachs were harvested. Staining of 
the stomachs for hematoxylin and eosin (HE), CD11c and CD4. Scale bars, 100µm. (E) 
Gastritis score in NTx–PD-1-/- mice at four weeks of age injected with anti-CCL20 
(n=5) or isotype control (n=10). Data are shown as the mean and error bars represent 
SD. *; P < 0.05. 
 







